Shanxi C&Y Pharmaceutical Group Co Ltd (300254) - Total Liabilities

Latest as of March 2026: CN¥1.07 Billion CNY ≈ $157.21 Million USD

Based on the latest financial reports, Shanxi C&Y Pharmaceutical Group Co Ltd (300254) has total liabilities worth CN¥1.07 Billion CNY (≈ $157.21 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 300254 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Shanxi C&Y Pharmaceutical Group Co Ltd - Total Liabilities Trend (2008–2025)

This chart illustrates how Shanxi C&Y Pharmaceutical Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Shanxi C&Y Pharmaceutical Group Co Ltd (300254) total assets.

Shanxi C&Y Pharmaceutical Group Co Ltd Competitors by Total Liabilities

The table below lists competitors of Shanxi C&Y Pharmaceutical Group Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
John Marshall Bancorp Inc NASDAQ:JMSB	USA	$2.13 Billion
Shenzhen Jianyi Decoration Group Co Ltd SHE:002789	China	CN¥9.81 Billion
Guangdong Real-Design Intelligent Technology Co. Ltd. SHE:301135	China	CN¥834.77 Million
Swancor Holding Co Ltd TW:3708	Taiwan	NT$6.08 Billion
Huafang Co Ltd SHG:600448	China	CN¥2.55 Billion
Electrovaya Inc. NASDAQ:ELVA	USA	$51.29 Million
Campine BR:CAMB	Belgium	€107.69 Million
Dinkelacker AG STU:DWB	Germany	€80.74 Million

Liability Composition Analysis (2008–2025)

This chart breaks down Shanxi C&Y Pharmaceutical Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Shanxi C&Y Pharmaceutical Group Co Ltd balance sheet independence to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.98	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.44	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.68	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanxi C&Y Pharmaceutical Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanxi C&Y Pharmaceutical Group Co Ltd (2008–2025)

The table below shows the annual total liabilities of Shanxi C&Y Pharmaceutical Group Co Ltd from 2008 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥1.05 Billion ≈ $153.39 Million	+10.40%
2024-12-31	CN¥949.55 Million ≈ $138.95 Million	+45.05%
2023-12-31	CN¥654.64 Million ≈ $95.79 Million	-23.40%
2022-12-31	CN¥854.64 Million ≈ $125.06 Million	+9.26%
2021-12-31	CN¥782.23 Million ≈ $114.46 Million	-15.70%
2020-12-31	CN¥927.91 Million ≈ $135.78 Million	+6.73%
2019-12-31	CN¥869.43 Million ≈ $127.22 Million	+54.03%
2018-12-31	CN¥564.47 Million ≈ $82.60 Million	+3.11%
2017-12-31	CN¥547.42 Million ≈ $80.10 Million	+14.59%
2016-12-31	CN¥477.74 Million ≈ $69.91 Million	+9.59%
2015-12-31	CN¥435.93 Million ≈ $63.79 Million	+21.71%
2014-12-31	CN¥358.17 Million ≈ $52.41 Million	+10.82%
2013-12-31	CN¥323.21 Million ≈ $47.30 Million	+83.65%
2012-12-31	CN¥175.99 Million ≈ $25.75 Million	+44.98%
2011-12-31	CN¥121.39 Million ≈ $17.76 Million	-7.51%
2010-12-31	CN¥131.25 Million ≈ $19.21 Million	-7.51%
2009-12-31	CN¥141.91 Million ≈ $20.77 Million	+20.82%
2008-12-31	CN¥117.45 Million ≈ $17.19 Million	--

About Shanxi C&Y Pharmaceutical Group Co Ltd

SHE:300254 China Drug Manufacturers - Specialty & Generic

Market Cap

$326.32 Million

CN¥2.23 Billion CNY

Market Cap Rank

#14528 Global

#4347 in China

Share Price

CN¥8.67

Change (1 day)

+0.46%

52-Week Range

CN¥7.27 - CN¥14.68

All Time High

CN¥31.09